drugset / Trial / NCT00906256
Clinical Pharmacology Study of AZD7295 in Healthy Subjects
RandomizedCrossoverQuadruple-blind
Summary
The purpose of this study is to determine the pharmacokinetic profile of oral doses of AZD7295 capsules in healthy subjects, and also to assess the effects of food as well as safety and tolerability.
Timeline
- Start
- 2009-04
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | AZD7295 | Small molecule | 260 mg | Oral |
| Comparator | AZD7295 | Small molecule | 455 mg | Oral |
| Comparator | AZD7295 | Small molecule | 650 mg | Oral |
Indications
No indication recorded.